Skip to main content
Clinical Trials/NCT03691324
NCT03691324
Completed
Not Applicable

Could Training in Inhalation Technique During the Hospital Stay and Discharge Services From the Pharmacy Reduce the Rate of Readmissions for COPD Patients? - A Pilot Study

Oslo University College1 site in 1 country40 target enrollmentSeptember 26, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulmonary Disease, Chronic Obstructive
Sponsor
Oslo University College
Enrollment
40
Locations
1
Primary Endpoint
Time to first readmission
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Inhalation drugs are essential in the treatment of COPD, in controlling symptoms and preventing exacerbations. The aim of this pilot study is to collect data necessary for the planning of future efficacy trials. We plan to assess the value of providing training in inhalation technique to hospitalized COPD patients. Data on rehospitalizations will be collected from the hospital's medical records and from the National Patient Registry . The inhalation technique of all recruited patients will de assessed at baseline. The patients will then be randomised 1:1 to the intervention or standard care group. The intervention consists of a drug counselling, focusing on inhalation technique. In addition patients in the intervention group will have their medicines personally delivered from the hospital pharmacy at discharge (discharge service). Patients will be asked to fill in questionnaires evaluating the inhalation training and the discharge service

Registry
clinicaltrials.gov
Start Date
September 26, 2018
End Date
January 15, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Oslo University College
Responsible Party
Principal Investigator
Principal Investigator

Liv Mathiesen

Associate professor

Oslo University College

Eligibility Criteria

Inclusion Criteria

  • Patients admitted to the pulmonary ward, the Medical Department, Oslo University Hospital, Oslo, Norway

Exclusion Criteria

  • previously included to the study
  • usually not administering their inhalation drugs themselves
  • using nebulizer chamber with their drug
  • who are contagious, thus restricting accessibility of personnel
  • who are not able to provide informed consent

Outcomes

Primary Outcomes

Time to first readmission

Time Frame: One year after discharge of the last patient

Time to readmission based on data from the national patient registry

Secondary Outcomes

  • Proportion of patients readmitted 3 months after discharge(3 months)
  • Improvement in patient reported symptom score (CAT-score) from baseline to 2 months after discharge(2 months after discharge)

Study Sites (1)

Loading locations...

Similar Trials